E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/15/2014 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse prices $965,000 return enhanced notes on Bristol-Myers

By Susanna Moon

Chicago, July 15 – Credit Suisse AG, London Branch priced $965,000 of 0% return enhanced notes due Aug. 3, 2015 linked to Bristol-Myers Squibb Co. shares, according to an FWP filing with the Securities and Exchange Commission.

The payout at maturity will be par plus double any stock gain, up to a maximum return of 30%.

Investors will be exposed to any losses.

J.P. Morgan Securities LLC is the agent.

Issuer:Credit Suisse AG, London Branch
Issue:Return enhanced notes
Underlying stock:Bristol-Myers Squibb Co. (Symbol: BMY)
Amount:$965,000
Maturity:Aug. 3, 2015
Coupon:0%
Price:Par
Payout at maturity:Par plus 200% of any stock gain, capped at 30%; exposure to any losses
Initial price:$48.62
Pricing date:July 11
Settlement date:July 16
Agent:J.P. Morgan Securities LLC
Fees:1%
Cusip:22547QQ66

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.